Questions about workplace screening come up constantly wherever kratom products are sold, whether the product is a chewable tablet, a 7 oh liquid shot or a leaf extract, and they deserve a careful answer rather than a quick yes or no. Whether a 7oh drug test result comes back positive depends far less on the product itself than on which test is ordered, how the lab confirms results and what the employer's policy says. This article explains how standard panels work, where kratom alkaloids fit in, why detection windows are hard to pin down, and what anyone subject to testing should do before relying on information they find online.
How Workplace Drug Testing Works
Most workplace programs follow a two-step process.
The first step is an initial screen, usually an immunoassay. These tests use antibodies designed to react with specific drug classes. They are fast and inexpensive, but they are built to detect particular chemical structures, not every substance a person might have taken.
The second step is a confirmatory test for any sample that screens positive. Confirmation is usually done with gas or liquid chromatography combined with mass spectrometry. These methods identify specific molecules rather than broad classes, which is why a confirmed result is far more reliable than a screen on its own.
In regulated programs, such as federal workplace testing and transportation testing, a Medical Review Officer (MRO) reviews confirmed results before they are reported to the employer. The MRO can ask the donor about legitimate explanations, such as prescriptions.
What a Standard Panel Includes
The panel most people mean when they say "standard drug test" is the panel used in federally regulated workplace testing, often called a five-panel test. Its core categories are:
- Marijuana (THC metabolite)
- Cocaine
- Amphetamines, including methamphetamine
- Opioids, including codeine, morphine, the heroin metabolite and several prescription opioids such as oxycodone and hydrocodone
- Phencyclidine (PCP)
Since July 7, 2025, the federal workplace guidelines from the Department of Health and Human Services have also included fentanyl in the authorized testing panel.
Expanded panels, often marketed as 10-panel or 12-panel tests, commonly add categories such as benzodiazepines, barbiturates and methadone.
Kratom alkaloids, including mitragynine and 7-OH, are not part of the federal workplace panel and are not a standard part of most expanded panels either.
Why Opioid Screens Are Not Designed for Kratom Alkaloids
Even though 7-OH interacts with opioid receptors in the body, its chemical structure is different from morphine, codeine and the other drugs that opioid immunoassays are designed to detect. Immunoassays respond to shape, not to how a compound acts in the body.
That said, published cross-reactivity data for kratom alkaloids on every commercial screening kit is limited, and no one can promise how a specific kit will respond. What can be said with more confidence is that a confirmatory test identifies specific molecules. A confirmation method looking for morphine or oxycodone would not report mitragynine or 7-OH as either of those drugs.
Specialized Kratom Testing Does Exist
The absence of kratom from standard panels does not mean it cannot be detected. Some laboratories offer tests that specifically look for mitragynine, 7-OH and their metabolites, typically using liquid chromatography with tandem mass spectrometry. That matters for leaf extract products such as kama kratom tablets, for mitragynine products sold as mit tabs, and for 7-OH products alike, because mitragynine is the main alkaloid in kratom leaf.
Employers outside federally regulated programs, treatment programs and courts can request these tests. Federally regulated programs, such as federal agency and transportation testing, are limited to the substances on the authorized federal panel. If you do not know what panel your employer uses, the safest assumption is that it could include kratom, and the right move is to read the policy or ask human resources.
Why Detection Windows Are Hard to Pin Down
Online sources often quote a precise number of days for how long 7-OH can be detected. In reality, there is little peer-reviewed research measuring detection windows for 7-OH in different sample types, and the figures that do circulate vary widely. The honest answer is that detection depends on several factors:
- Frequency of use. Regular use generally leads to longer detection than a single occasion.
- Amount. Larger amounts take longer to clear.
- Individual metabolism. Liver enzymes, age, body composition and overall health all influence how quickly compounds are processed.
- Hydration and kidney function. These affect urine concentration.
- Sample type. Urine, blood, saliva and hair each have different detection windows for most substances, with hair usually reflecting the longest period.
- Test sensitivity. Each lab sets its own cut-off levels, which determine what counts as a positive result.
It also helps to separate two questions that often get blended together. Asking how long does 7oh last is a question about the duration of effects. Asking how long it can be detected is a question about metabolites in a sample. For many substances the detection window is longer than the duration of effects, but for 7-OH there is little published data either way, and one does not predict the other.
Articles that answer how long does 7oh take to kick in, or how long its effects last, address timing, not detection. Neither onset nor duration tells you how long a compound remains detectable, so treat them as separate topics.
If You Are Subject to Testing
Anyone in a job, program or legal situation that involves testing should keep a few practical points in mind.
1. Read the written policy. Some employers ban kratom products outright, whether or not their test detects them. A policy violation can have consequences even without a positive result.
2. Know whether your role is regulated. Safety-sensitive transportation roles, for example, are covered by federal testing regulations with strict rules on what employees can use.
3. Be honest with the MRO. If a result is under review, the MRO is the person who considers legitimate explanations. Withholding information rarely helps.
4. Do not rely on detox products or internet shortcuts. Products that claim to "clean" a sample are unreliable, and tampering with a sample is treated as a refusal in many programs.
5. Watch for legal changes. If the pending federal order on 7-OH is published, employer policies may change quickly, and the consequences of a confirmed result could become more serious.
Testing Outside the Workplace
Workplace programs are only one setting where testing happens. Treatment programs, probation and pretrial supervision, and some professional licensing boards also use drug testing, and they often have more flexibility over which substances they include. A program that is specifically concerned about opioid-like substances may decide to add kratom alkaloids to its menu even when an employer would not.
The rules in these settings are usually set by the program or the court rather than by federal workplace guidelines. If you are in one of these programs, the written conditions you agreed to are what count, and the program staff are the right people to ask about what is tested and what is permitted. Assuming that a substance is acceptable because a routine employment test would not detect it is a risky approach in any supervised setting.
How Federal Scheduling Could Change the Picture
As of early October 2026, the DEA had published a notice of intent to temporarily schedule 7-OH above a specified threshold, but no final order had appeared. Three related lab-derived compounds, MP, MGM-15 and MGM-16, were placed in Schedule I on August 26, 2026.
If 7-OH is scheduled, more employers, courts and treatment programs may choose to add kratom alkaloids to their testing menus. Scheduling would not automatically add 7-OH to the federal workplace panel, which only HHS can change, but non-regulated employers and programs can add tests at any time.
Frequently Asked Questions
Will 7-OH cause a false positive for opioids?
Opioid immunoassays are not designed to detect 7-OH, and confirmatory testing identifies specific molecules. Because cross-reactivity data is limited for some kits, no one can guarantee how every initial screen will respond.
Can an employer test specifically for kratom?
In most programs that are not federally regulated, yes. Kratom-specific tests for mitragynine and 7-OH are available from some laboratories. Federally regulated programs can only test for substances on the authorized federal panel, which does not include kratom alkaloids.
How long is 7-OH detectable?
There is no well-established figure. Detection depends on frequency, amount, metabolism, sample type and the lab's cut-off levels.
